Allergen immunotherapy started
Antihypertensive agent surveillance
Antihypertensive medication surveillance done
High risk medication monitoring
High risk medication monitoring indicated
Immunodeficiency due to long term therapeutic use of drug
Long term antidepressant medication therapy
Long term antipsychotic medication therapy
Long term antiviral therapy
Long term anxiolytic medication therapy
Long term apremilast therapy
Long term current use of abatacept
Long term current use of abatacept orencia)
Long term current use of acetaminophen tylenol)
Long term current use of acitretin soriatane)
Long term current use of adalimumab humira)
Long term current use of amiodarone
Long term current use of anakinra kineret)
Long term current use of anticonvulsant
Long term current use of aralen chloroquine)
Long term current use of azathioprine
Long term current use of belimumab benlysta)
Long term current use of cannabis
Long term current use of clozapine clozaril)
Long term current use of cyclophosphamide
Long term current use of cyclosporine
Long term current use of etanercept
Long term current use of etanercept enbrel)
Long term current use of felbamate felbatol)
Long term current use of filgrastim neupogen)
Long term current use of golimumab simponi)
Long term current use of humira
Long term current use of hydroxychloroquine plaquenil)
Long term current use of infliximab remicade)
Long term current use of isotretinoin accutane)
Long term current use of leflunomide arava)
Long term current use of lenalidomide revlimid)
Long term current use of lithium
Long term current use of medication for add and or adhd
Long term current use of medication for attention deficit disorder add) or attention deficit hyperactivity disorder adhd)
Long term current use of methotrexate
Long term current use of mycophenolate
Long term current use of pharmaceutical gold
Long term current use of plaquenil
Long term current use of remicade
Long term current use of retinoid
Long term current use of rituximab rituxan)
Long term current use of sirolimus rapamune)
Long term current use of sulfasalazine azulfidine)
Long term current use of tacrolimus
Long term current use of tocilizumab
Long term diuretic therapy
Long term drug therapy
Long term erythropoiesis stimulating agent therapy
Long term growth hormone therapy
Long term intravenous immune globulin therapy
Long term mercaptopurine therapy
Long term methotrexate user
Long term testosterone cypionate oil based intramuscular injection) therapy
Long term tofacitinib therapy
Long term use certolizumab pegol
Long term ustekinumab therapy
Long-term current use of acitretin
Long-term current use of anakinra
Long-term current use of antidepressant medication
Long-term current use of antipsychotic medication
Long-term current use of antiviral
Long-term current use of anxiolytic medication
Long-term current use of apremilast
Long-term current use of aralen
Long-term current use of belimumab
Long-term current use of certolizumab pegol
Long-term current use of clozapine
Long-term current use of diuretic
Long-term current use of erythropoiesis stimulating agent
Long-term current use of felbamate
Long-term current use of filgrastim
Long-term current use of golimumab
Long-term current use of growth hormone
Long-term current use of high dose acetaminophen
Long-term current use of hydroxychloroquine
Long-term current use of intravenous immune globulin
Long-term current use of isotretinoin
Long-term current use of leflunomide
Long-term current use of lenalidomide
Long-term current use of medicinal gold
Long-term current use of mercaptopurine
Long-term current use of rituximab
Long-term current use of sirolimus
Long-term current use of sulfasalazine
Long-term current use of testosterone cypionate
Long-term current use of tofacitinib
Long-term current use of ustekinumab
Malaria prophylaxis given
Medication surveillance, antihypertensive
Monitoring of long term therapeutic drug use done
Opioid dependence moderate use disorder) on agonist therapy, in early remission
Opioid dependence moderate use disorder) on agonist therapy, in sustained remission
Opioid dependence severe use disorder) on agonist therapy, in early remission
Opioid dependence severe use disorder) on agonist therapy, in sustained remission
Opioid dependence, moderate use, on agonist therapy, in early remission
Opioid dependence, moderate use, on agonist therapy, in sustained remission
Opioid dependence, severe use on agonist therapy, in early remission
Opioid dependence, severe use on agonist therapy, in sustained remission
Prophylactic preventative) anticoagulation therapy
Prophylactic preventative) immunotherapy
Prophylactic preventative) malaria therapy
Prophylactic preventative) medication prescription
Prophylactic anticoagulation given
Prophylactic medication given
Therapeutic drug induced immunosuppression, long term use
Z79.899
Z79.899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM Z79.899 became effective on October 1, 2022.
This is the American ICD-10-CM version of Z79.899 – other international versions of ICD-10 Z79.899 may differ.